N057462 N0 Ruling Active

The tariff classification of AGN 210669 from Italy

Issued May 15, 2009 by U.S. Customs and Border Protection.

Tariff classification

HTS codes: 2937.50.0000

Headings: 2937

Product description

The subject product, AGN 210669, is a prostaglandin indicated for the potential treatment of Glaucoma. It is currently in phase I and phase II clinical trials.

CBP rationale

The applicable subheading for the AGN 210669 will be 2937.50.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues.

Full text

N057462 May 15, 2009 CLA-2-29:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2937.50.0000 Ms. Freya Wilkes Allergan 2525 Dupont Drive Irvine, CA 92612 RE: The tariff classification of AGN 210669 from Italy Dear Ms. Wilkes: In your letter dated April 10, 2009, you requested a tariff classification ruling. The subject product, AGN 210669, is a prostaglandin indicated for the potential treatment of Glaucoma. It is currently in phase I and phase II clinical trials. The applicable subheading for the AGN 210669 will be 2937.50.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

Searching CBP rulings the smart way

TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.

Book a demo →